MOST NOTEWORTHY:

• Wachovia downgraded shares of Abbott Labs (NYSE: ABT) to Market Perform from Outperform reflect several challenges to the company's key franchises. In particular, Wachovia cites the potential delay of the drug-eluting stent Xience launch in the U.S. and decelerating growth of Humira.
  
• ABN Amro downgraded shares of Barclays (NYSE: BCS) to Hold from Buy to reflect the capital markets, lower UK bank non-interest income and higher bad debts.
  
• Oppenheimer downgraded shares of SanDisk Corporation (NASDAQ: SNDK) to Neutral from Buy as they expect many of the advantages that drove shares to unwind in Q4 and into 1H08.
  
• Mission West Properties (NYSE: MSW) was downgraded to Hold from Buy at Stifel, as they now believe the possibility of a sale is 50%/50% and could be pushed back to 1H08.
  
• Think Equity downgraded shares of Texas Instruments (NYSE: TXN) to Source of Funds from Accumulate as they believe competition could hinder Q4 and 2008 growth for wireless.

• Citigroup downgraded Xyratex Ltd (NASDAQ: XRTX) and Valueclick (NASDAQ: VCLK) to Hold from Buy.
  
• Piper downgraded Nasdaq Stock Market (NASDAQ: NDAQ) to Market Perform from Outperform.
  
• Lehman downgraded Burlington Northern Santa Fe Corp (NYSE: BNI) to Equal Weight from Overweight and CSX Corporation (NYSE: CSX) to Underweight from Equal Weight.
  
• UBS downgraded Molson Coors (NYSE: TAP) to Neutral from Buy.

Analyst downgrades: ABT, BCS, SNDK, MSW and TXN originally appeared on BloggingStocks on Thu, 11 Oct 2007 11:10:00 EST. Please see our terms for use of feeds.